AJANTA PHARMA
Back to Income Statement
|
AJANTA PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹816 Cr | ₹588 Cr | ₹713 Cr | ₹654 Cr | ₹468 Cr |
What is the latest Consolidated Net Profit of AJANTA PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹816 Cr |
| Mar2024 | ₹588 Cr |
| Mar2023 | ₹713 Cr |
| Mar2022 | ₹654 Cr |
| Mar2021 | ₹468 Cr |
How is Consolidated Net Profit of AJANTA PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹816 Cr | 38.81 | |
| Mar2024 | ₹588 Cr | -17.50 | |
| Mar2023 | ₹713 Cr | 8.99 | |
| Mar2022 | ₹654 Cr | 39.81 | |
| Mar2021 | ₹468 Cr | - | |
Compare Consolidated Net Profit of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹36,169.2 Cr | 6.9% | -3.5% | 12.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| CIPLA | ₹97,846.7 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | 6.9% |
-3.5% |
12.6% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses